Brief: Electrocore "Vanquish" Clinical Trial Suggests Safety & Efficacy Of NVNS For Treatment Of Headache Associated With Subarachnoid Hemorrhage

electroCore,.

10/10/2023 13:08

Oct 10 (Reuters) - electroCore, Inc.  ECOR.O :
    * ELECTROCORE. - "VANQUISH" CLINICAL TRIAL (N=40) SUGGESTS
SAFETY
& EFFICACY OF NVNS FOR TREATMENT OF HEADACHE ASSOCIATED WITH
SUBARACHNOID HEMORRHAGE
    * ELECTROCORE - "NOVIS" CLINICAL TRIAL (N=150) OF NVNS FOR
ACUTE
TREATMENT OF ISCHEMIC STROKE WILL COMPLETE RECRUITMENT IN 2023

Source text for Eikon:  ID:nGNX29Pf0W 
Further company coverage:  ECOR.O 

 ((Reuters.Briefs@thomsonreuters.com))